Recruiting
Magnetic Resonance Imaging in Radiotherapy for Breast Cancer
About this study
This is a single-center, prospective pilot study evaluating feasibility and efficacy of incorporating magnetic resonance imaging (MRI) simulation into the planning of radiation treatment (RT) for breast cancer.
- Condition
- Breast Cancer
- Tested
- Magnetic Resonance Imaging Simulation
- Sponsor
- University of California, San Francisco
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 8
- Minimum age: 18 years
- Study condition: Breast Cancer
- Participants with an Eastern Cooperative Oncology Group (ECOG) performance status \<=2 (or Karnofsky ≥\>=60%, see Appendix A).
- Participants with the ability to understand and the willingness to sign a written informed consent document.
- Participants may separately enroll on therapeutic clinical trials when they enroll on this trial. Note: All interventions on this protocol are standard of care, so enrollment on other therapeutic protocols is allowed at the discretion of the treating physician.
- Patients must have pathologically confirmed invasive or in situ breast cancer.
- Patients must have tumors in which adjuvant breast radiotherapy following breast conserving surgery is indicated, as determined by the treating physician.
- Patients must be female. Note: Male patients are excluded due to the rarity of male breast cancer and difficulty in pursuing breast conserving surgery for male patients.
Exclusion 2
- Participants with a contraindication to MRI per the MRI checklist.
- Patients with breast tumor or tumor bed not visualized at CT or MRI during RT planning.
Where
1 site, 1 recruiting
University of California, San Francisco
San Francisco, California, United States
Contact
-
Imani Dunn
877-827-3222 Imani.Dunn@ucsf.edu
Potential match only. Final eligibility is determined by the study team.